Evidence map›Paper›PMID 41552478›Full record

ArticleACS omega2026

Glucuronidated Hydroxyphenylacetic and Hydroxyphenylpropanoic Acids as Standards for Bioavailability Studies with Flavonoids.

Viola Janouchová, Martina Hurtová, Hana Kočová Vlčková, Zuzana Lomozová, Jana Pourová, Lucie Nováková, Lucie Petrásková, Helena Pelantová, Josef Cvačka, Kateřina Valentová

Abstract read
In one paragraph

Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Viola JanouchováInstitute of Microbiology of the Czech Academy of Sciences, Vídeňská 1083, Prague CZ-142 00, Czech Republic.
Martina HurtováInstitute of Microbiology of the Czech Academy of Sciences, Vídeňská 1083, Prague CZ-142 00, Czech Republic.ORCID https://orcid.org/0000-0002-1470-4450
Hana Kočová VlčkováFaculty of Pharmacy, Charles University, Akademika Heyrovského 1203, Hradec Králové CZ-50005, Czech Republic.
Zuzana LomozováFaculty of Pharmacy, Charles University, Akademika Heyrovského 1203, Hradec Králové CZ-50005, Czech Republic.ORCID https://orcid.org/0000-0001-9205-7714
Jana PourováFaculty of Pharmacy, Charles University, Akademika Heyrovského 1203, Hradec Králové CZ-50005, Czech Republic.
Lucie NovákováFaculty of Pharmacy, Charles University, Akademika Heyrovského 1203, Hradec Králové CZ-50005, Czech Republic.
Lucie PetráskováInstitute of Microbiology of the Czech Academy of Sciences, Vídeňská 1083, Prague CZ-142 00, Czech Republic.ORCID https://orcid.org/0000-0002-7052-5115
Helena PelantováInstitute of Microbiology of the Czech Academy of Sciences, Vídeňská 1083, Prague CZ-142 00, Czech Republic.
Josef CvačkaInstitute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo náměstí 542/2, Prague CZ-160 00, Czech Republic.ORCID https://orcid.org/0000-0002-3590-9009
Kateřina ValentováInstitute of Microbiology of the Czech Academy of Sciences, Vídeňská 1083, Prague CZ-142 00, Czech Republic.ORCID https://orcid.org/0000-0002-7714-5350

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glucuronidation is a major phase II biotransformation of (poly)-phenols leading to potentially bioactive metabolites. Due to the limited availability of authentic standards, in this work, we have focused on the glucuronidation of a series of mono- and dihydroxyphenolic acids. Their reactivity with two glucuronidation reagents, 2,3,4-triaceto-1-bromo-α-d-glucuronic acid methyl ester and Schmidt imidate, was investigated. The use of Schmidt imidate led to the successful synthesis of six target glucuronides in moderate to excellent yields. Subsequent deprotection of these compounds afforded the final glucuronides of 2-hydroxyphenylacetic, 3-hydroxyphenylacetic, 4-hydroxyphenylacetic, 3,4-dihydroxyphenylacetic, 3-(4-hydroxyphenyl)-propionic, and 3-(3,4-dihydroxyphenyl)-propionic acid. These compounds, which are plausible polyphenolic metabolites, were fully characterized and used in a pilot metabolic study in rats after administration of a hawthorn berry extract (475 mg/kg). UHPLC-HRMS analysis identified two of the glucuronides, namely 4-hydroxyphenylacetic acid glucuronide and 3-hydroxyphenylacetic acid glucuronide in rat plasma, confirming their

Identifiers

PMID41552478
PMCPMC12809306

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.